Logo image
Sign in
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors’ response
Journal article

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors’ response

Christine Katlama, Lambert Assoumou, Marc-Antoine Valantin, Cathia Soulié, Esteban Martinez, Lydie Béniguel, Olivier Bouchaud, François Raffi, Jean-Michel Molina, Soraya Fellahi, …
Journal of Antimicrobial Chemotherapy, Vol.75(12), pp.3699-3700
01/12/2020
PMID: 32954404

Abstract

Anti-HIV Agents HIV Infections Humans Nitriles Pyridazines Pyrimidines Raltegravir Potassium
url
Find in HALView

Metrics

1 Record Views

Details

Logo image